Neuroscience

Visualizing multiple sclerosis with a new MRI procedure

Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects about 2.9 million people worldwide, and about 15,000 in Switzerland alone. One key feature of the disease is that ...

Neuroscience

Possible biomarker of MS-like autoimmune disease discovered

It has been known for several years that the diagnosis "multiple sclerosis" conceals a whole range of different illnesses, each requiring customized treatment. Researchers at the University of Basel and the University Hospital ...

Diseases, Conditions, Syndromes

Multiple sclerosis: Myelin may be detrimental to nerve fibers

Multiple sclerosis (MS) affects millions of people worldwide, and there is currently no cure for this disease of the central nervous system. Damage to the nerve fibers, also called axons, is responsible for the severity of ...

Medications

New drug candidate slows the progression of adrenoleukodystrophy

The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective ...

Neuroscience

Fresh insights into inflammation, aging brains

Results from a new study by Harvard researchers just published in Cell offer insights into the relationship between inflammation and the cognitive impairment we experience as we age, and suggest the possibility that it may ...

Neuroscience

In Krabbe disease, neurons may bring about their own destruction

The gene defect underlying Krabbe disease causes degeneration of neurons directly, independent of its effects on other cell types, according to a new study publishing July 5 in the open-access journal PLOS Biology by Daesung ...

page 2 from 16